STOCK TITAN

Evogene Ltd. (EVGN) investors lift beneficial stake to 19.35% of shares

(High)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Evogene Ltd. shareholders led by L.I.A. Pure Capital Ltd. and Invest Pro Shukai Hon Ltd. report increased ownership following open-market purchases of 533,088 American Depositary Shares (ADSs) by Pure Capital using working capital.

After these transactions, the reporting persons collectively report beneficial ownership of 3,057,488 Ordinary Share equivalents, representing 19.35% of Evogene’s outstanding share capital, based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026. Pure Capital has sole dispositive power over 2,501,388 ADSs and 56,100 Ordinary Shares (about 16.19% of the company), while Invest Pro has sole dispositive power over 500,000 ADSs (about 3.16%). Voting power over 3,001,388 ADSs and 56,100 Ordinary Shares is shared under an oral voting agreement. Kfir Silberman and Ron Yair Peled may be deemed beneficial owners through their control of Pure Capital and Invest Pro, respectively, but each disclaims beneficial ownership beyond their pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Additional ADSs acquired 533,088 ADSs ADSs acquired by Pure Capital using working capital
Aggregate beneficial ownership 3,057,488 Ordinary Shares Total Ordinary Share equivalents beneficially owned by reporting persons
Ownership percentage 19.35% Percent of Evogene’s 15,801,407 outstanding Ordinary Shares
Shares outstanding 15,801,407 Ordinary Shares Outstanding as of July 27, 2026 per Evogene proxy statement
Pure Capital sole dispositive stake 2,501,388 ADSs and 56,100 Ordinary Shares Represents approximately 16.19% of outstanding share capital
Invest Pro sole dispositive stake 500,000 ADSs Represents approximately 3.16% of outstanding share capital
Event date 08/10/2026 Date of event triggering the amendment
American Depositary Shares financial
"American Depositary Shares, each representing one (1) Ordinary Share"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
beneficial owner financial
"may be deemed a beneficial owner of any ADSs or Ordinary Shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
dispositive power financial
"Pure Capital has the sole dispositive power over 2,501,388 ADSs"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
pecuniary interest financial
"disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest"
Schedule 13(d) regulatory
"for purposes of Schedule 13(d) of the Exchange Act"
oral voting agreement financial
"Voting power with respect to the reported securities is shared pursuant to the terms of the oral voting agreement"

FAQ

What ownership change in Evogene (EVGN) does this Schedule 13D/A report?

The amendment reports that the group led by L.I.A. Pure Capital Ltd. now beneficially owns 3,057,488 Ordinary Share equivalents of Evogene, representing 19.35% of the company’s 15,801,407 outstanding Ordinary Shares as of July 27, 2026.

How many additional Evogene (EVGN) ADSs did Pure Capital acquire and how were they funded?

Pure Capital acquired 533,088 additional ADSs of Evogene. These purchases were funded using working capital and were executed in the open market, increasing the reporting persons’ aggregate beneficial ownership stake in the company.

What level of control does Pure Capital report over Evogene (EVGN) shares?

Pure Capital reports sole dispositive power over 2,501,388 ADSs and 56,100 Ordinary Shares, representing about 16.19% of Evogene’s outstanding share capital, and shared voting power over 3,001,388 ADSs and 56,100 Ordinary Shares under an oral voting agreement.

What is Invest Pro Shukai Hon Ltd.’s stake in Evogene (EVGN) after this amendment?

Invest Pro Shukai Hon Ltd. has sole dispositive power over 500,000 ADSs of Evogene, representing approximately 3.16% of the company’s outstanding share capital, and participates in shared voting power over 3,001,388 ADSs and 56,100 Ordinary Shares.

On what share count is the 19.35% Evogene (EVGN) ownership calculation based?

The reported 19.35% beneficial ownership in Evogene is calculated using a total of 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as disclosed in Evogene’s 2026 Annual General Meeting proxy statement furnished on July 31, 2026.

Who are the individuals behind the reporting entities in this Evogene (EVGN) Schedule 13D/A?

The securities are held by entities. Kfir Silberman is the officer, sole director, chairman, and controlling shareholder of L.I.A. Pure Capital Ltd., while Ron Yair Peled is the owner and Chief Executive Officer of Invest Pro Shukai Hon Ltd..

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





M4119S187

(CUSIP Number)
Kfir Silberman
L.I.A. Pure Capital Ltd., 20 Raoul Wallenberg Street
Tel Aviv, L3, 6971916
972-3-7175777

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
08/10/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The percentage of ordinary shares, par value NIS 0.20 per share, of Evogene Ltd. (the "Ordinary Shares" and the "Issuer", respectively) beneficially owned by the Reporting Person is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as reported by the Issuer in the Issuer's Proxy Statement for its 2026 Annual General Meeting of Shareholders, dated July 31, 2026, attached as Exhibit 99.2 to the Issuer's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on July 31, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The securities reported on this Schedule are held by L.I.A. Pure Capital Ltd. ("Pure Capital"). Kfir Silberman is the officer, sole director, chairman of the board of directors and controlling shareholder of Pure Capital. (2) The percentage of Ordinary Shares beneficially owned by the Reporting Person is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as reported by the Issuer in the Issuer's Proxy Statement for its 2026 Annual General Meeting of Shareholders, dated July 31, 2026, attached as Exhibit 99.2 to the Issuer's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on July 31, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The percentage of Ordinary Shares beneficially owned by the Reporting Person is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as reported by the Issuer in the Issuer's Proxy Statement for its 2026 Annual General Meeting of Shareholders, dated July 31, 2026, attached as Exhibit 99.2 to the Issuer's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on July 31, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The securities reported on this Schedule are held by Invest Pro Shukai Hon Ltd. ("Invest Pro"). Ron Yair Peled is the owner and the Chief Executive Officer of Invest Pro. (2) The percentage of Ordinary Shares beneficially owned by the Reporting Person is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as reported by the Issuer in the Issuer's Proxy Statement for its 2026 Annual General Meeting of Shareholders, dated July 31, 2026, attached as Exhibit 99.2 to the Issuer's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on July 31, 2026.


SCHEDULE 13D


L.I.A. Pure Capital Ltd.
Signature:/s/ Kfir Silberman
Name/Title:Kfir Silberman/Chairman and Chief Executive Officer
Date:08/13/2026
Kfir Silberman
Signature:/s/ Kfir Silberman
Name/Title:Kfir Silberman
Date:08/13/2026
Invest Pro Shukai Hon Ltd.
Signature:/s/ Eli Zamir
Name/Title:Eli Zamir/Director
Date:08/13/2026
Ron Yair Peled
Signature:/s/ Ron Yair Peled
Name/Title:Ron Yair Peled
Date:08/13/2026